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Abstract
In many clinical and scientific situations the optimal neuroimaging sequence
may not be known prior to scanning and may differ for each individual being
scanned, depending on the exact nature and location of abnormalities.
Despite this, the standard approach to data acquisition, in such situations,
is to specify the sequence of neuroimaging scans prior to data acquisition
and to apply the same scans to all individuals. In this paper, we propose
and illustrate an alternative approach, in which data would be analysed as it
is acquired and used to choose the future scanning sequence: Active
Acquisition. We propose three Active Acquisition scenarios based around
multiple MRI modalities. In Scenario 1, we propose a simple use of
near-real time analysis to decide whether to acquire more or higher
resolution data, or acquire data with a different field of view. In Scenario 2,- -
we simulate how multimodal MR data could be actively acquired and
combined with a decision tree to classify a known outcome variable (in the
simple example here, age). In Scenario 3, we simulate using Bayesian
optimisation to actively search across multiple MRI modalities to find those
which are most abnormal. These simulations suggest that by actively
acquiring data, the scanning sequence can be adapted to each individual.
We also consider the many outstanding practical and technical challenges
involving normative data acquisition, MR physics, statistical modelling and
clinical relevance. Despite these, we argue that  Active Acquisition allows
for potentially far more powerful, sensitive or rapid data acquisition, and
may open up different perspectives on individual differences, clinical
conditions, and biomarker discovery.
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Introduction
Neuroimaging involves trade-offs; whether for clinical diagno-
sis, patient stratification, or biomarker discovery. For example, 
with a typical MRI scan, there are substantial practical constraints 
(money, patient comfort and compliance, radiological reporting) 
which means decisions have to be taken as to what kind of scan 
to perform, where in the brain scan, and the scan resolution. The 
standard approach is to make these decisions before scanning 
commences, acquiring the data then analysing it. However, the 
optimal resolution/type of scan will depend on what is being 
investigated, and the type and location of the pathology or 
abnormalities, and may not be known a priori.
Here, we propose an alternative approach using active learn-
ing for real-time optimisation of neuroimaging data acquisition; 
providing illustrative examples. Broadly, in our approach data 
acquisition and analysis are not separated; instead data is 
analysed as it is acquired and used to guide subsequent data 
acquisition, in a closed-loop. The word game hangman is a 
simple illustration of a form of active learning (as is predictive 
text messages and search engine auto-completion): a letter is 
guessed, and whether it is present or not is then evaluated; this 
information is then used to narrow the search for the next 
letter. Active learning approaches are potentially far more 
efficient (in terms of scanner time) than treating acquisition and 
analysis as separate phases. A non-active learning version of 
hangman would involve guessing all the letters at the start of 
the game and then evaluating them all at once without any 
feedback; in most situations, this would be a highly inefficient 
strategy.
We have previously demonstrated that active learning can be 
used to guide the choice of experimental paradigm in functional 
MRI (Lorenz et al., 2016): with substantial increases in terms of 
speed, searching over many experimental parameters far quicker 
than an exhaustive search. This allows for far broader research 
questions to be asked (Lorenz et al., 2018). Active learning also 
has another important feature; they involve a prediction and 
testing cycle, with the learner having to make predictions that are 
then tested with out-of-sample data. This potentially increases the 
replicability of analyses and reduces the ability for post-hoc bias 
(Lancaster et al., 2018; Lorenz et al., 2017).
The work presented here investigates the use of sequential deci-
sion-making to select the type of scan, using information 
gained from previous scans actively seek out brain abnormalities 
or make diagnostic predictions. This requires data to be collected 
and analysed in near real-time; however, to illustrate the potential 
power of this approach our demonstrations use previously collected 
data, by simulating the real-time analysis aspect.
Video 1 presents a video overview of active acquisition: (i) scan 
parameters are chosen (e.g., modality or acquisition parameters 
such as resolution, repetition time or echo time); (ii) the scan is 
acquired; (iii) pre-processed; and, (iv) acquired data is com-
pared to an existing normative dataset. The loop then continues 
with the information in (iv) used to optimise the next scan (or 
decide whether sufficient data have been collected to stop 
scanning). We explore using Active Acquisition in three different 
scenarios with T1-weighted MR images:
1)    Finding a localised structural anomaly (e.g., locating a 
focal lesion).
2)    Choosing the optimal scanning modality to actively detect 
abnormalities.
3)    Actively choosing the type of scan to characterize an aspect 
of the individual being scanned (e.g., age).
Active acquisition for multimodal neuroimaging
1 Data File
Video 1: General illustrative video of one active acquisition 
approach for structural neuroimaging. (If video fails to play, 
it is also available in supplementary material or from the Github 
repository).
https://dx.doi.org/10.6084/m9.figshare.7296920.v1
Methods
Scenario 1: Changing structural scan resolution to detect 
stroke pathology
Our rationale is to start at a low image resolution for a (very 
rapid) whole brain scan, before acquiring higher resolution scans 
if the brain appears to be abnormal. This way, it is possible to 
efficiently image a focal pathology, such as a lesion or tumour, 
and to rapidly estimate its spatial location and establish whether 
more data needs to be acquired, potentially with a restricted field 
of view focused on the site of the abnormality.
Choice of scan parameters. For our illustrative simulation, we 
used structural scans collected offline (Dataset 1 (Leech & Cole, 
2018)). In practice they would be acquired and analysed 
online. Practical challenges and limitations to acquiring these 
data, as well as consider possible methods to mitigate these 
challenges, as outlined in the Discussion section.
At each iteration, the scan is divided into three equally sized 
volumes, along the z-dimension. The ‘outlier distance’ (defined 
below) is then quantified for each third by reference to the 
distribution in an independent normative sample. The volume 
with the highest outlier distance is then selected and the next 
scan “acquired”; covering the same section of the volume, but 
with the resolution doubled. The process was repeated three 
times until the maximum resolution of 1mm3 voxel was achieved. 
The choice of resolution and number of sub-divisions (and 
other scanner parameters) presented in this scenario is relatively 
arbitrary. Future work will need to establish the optimal approach 
for a given clinical or scientific question. There will always be a 
trade-off between multiple comparisons and precision when 
assessing; here we chose a very coarse approach which should 
be sufficient, given the focal and macroscopic nature of the 
brain injury (i.e., lesion). In clinical or scientific applications, a 
more sophisticated approach would probably be required, that 
chooses the brain region for the outlier detection (and poten-
tially subsequent more targeted acquisition), related to the size 
and location of the pathology or abnormality, possibly changing 
orientation, and the image field-of-view in the process.
Page 3 of 19
Wellcome Open Research 2018, 3:145 Last updated: 15 MAY 2019
Outlier distance from normative sample. The extent to which 
a participant’s image was different from the normative sample 
was quantified, restricted to the resolution and coverage of the 
specific scan. The median distance between an individual’s scan 
and each participant in the normative dataset was calculated 
using the median absolute deviation (in Euclidean distance) 
of signal intensity averaged across all voxels. This results in a 
single value of outlier distance. The choice of outlier quantifica-
tion depends on the type of data being acquired and the question 
being asked. We opted for the median absolute deviation because 
it is a simple measure that is relatively robust to violations of 
normality assumptions. However, we note that many other more 
sensitive outlier measures could also be used (e.g., measures taking 
into account covariance across voxels, (Fritsch et al., 2012)).
Scenario 2: Active multimodal stratification of individual 
differences
In this scenario, Active Acquisition is used to choose the 
modality of the scan to achieve a given goal. The rationale is that 
the optimal scanning modality for assessing an individual, for 
example to quantify their relationship to a normative sample, 
will vary for different individuals; when performing a battery of 
scans, each individual may have a different set of scans and a 
different acquisition order.
In Scenario 2, we use multimodal imaging to quantify individual 
variability. This type of analysis could be relevant when 
classifying or stratifying individuals into scientifically or 
clinically relevant groups. To illustrate this, we use the Cam-CAN 
dataset (Shafto et al., 2014) and with the task of predicting 
chronological age from neuroimaging data. Predicting age is 
a useful example case for active multimodal imaging because 
there are large datasets available, there is little ambiguity about 
label validity (unlike many clinical descriptions), age is associ-
ated with large-scale neural changes (e.g., (Good et al., 2001) and 
“brain-predicted age” has been shown to relate to many other 
health related biomarkers (e.g., Cole et al., 2018). Cam-CAN is a 
particularly useful dataset to assess this source of individual 
variability since the age distribution of the participants is 
approximately equally balanced across seven decades from 
20s to 80s.
To instigate Active Acquisition in this case, we simulate the 
active learning process by fitting a decision tree regression 
model to the six modalities of Cam-CAN; predictions of chron-
ological age were the outcome measure. This is because: a 
low-depth decision tree would not include all modalities, just 
those important for predicting age; making the decision sequen-
tially (i.e., modality by modality) rather than simultaneously, 
thus it is well-suited for Active Acquisition, and finally; allows 
different individuals to have different scans and different orders 
of scans.
A holdout dataset was created with 20% of the individuals, 
selected randomly (the data partition was performed once rather 
than pooling across multiple, randomly generated partitions). 
A decision tree was fit to the remaining 80% of individuals’ six 
imaging modalities as the predictor variables and their ages in 
years as the outcome variable. The model hyper-parameters 
(tree depth, number of leaves, etc.) were estimated with Bayesian 
optimisation (Leech & Cole, 2018). Subsequently, the decision 
tree was evaluated with the holdout participants. The applica-
tion of the decision tree (the sequential decision process) to each 
individual in the holdout group, could be performed in real-time 
to new participants in exactly the same way. For comparison, 
we also fit a standard support vector regression, with hyper- 
parameters also optimised with Bayesian optimisation, to the 
same data (see Matlab code, (Leech & Cole, 2018)) which used 
all data modalities simultaneously.
Scenario 3: Active discovery of individual differences with 
multi-modal imaging
Whereas Scenario 2 focuses on quantifying how an individual 
varies along some dimension (e.g., age), in Scenario 3, we 
attempt to actively learn which modality an individual is most 
likely to be an outlier in. This could be useful for efficiently 
finding pathology in an individual or for discovering biomar-
kers; particularly, when there are a large number of possible 
modalities to choose from and a limited amount of scanning 
time/participant tolerance of scanning (Leech & Cole, 2018).
To illustrate Scenario 3, we again used the Cam-CAN dataset, 
as per Scenario 2. In addition, we included a Bayesian optimisa-
tion algorithm (Shahriari et al., 2016) to actively learn which 
modality is most abnormal (as quantified by the magnitude of 
outlier measurement). Bayesian optimisation is particularly well 
suited for this type of problem when the objective underlying 
function is unknown and costly to evaluate and relatively robust to 
the presence of noise in the data.
For optimisation to work efficiently, the acquisition function 
needs to take advantage of existing information; in this case the 
covariance across individuals for different modalities. Therefore, 
we split the data into two: 80% of the Cam-CAN participants 
were used to estimate the space (across modalities) for the 
algorithm to search across. To do this, we converted each 
modality to a z-score, then performed a factor analysis (using 
Matlab) and calculated a single factor. We then reorganized the 
modalities for the search space for the Bayesian optimisation 
in terms of weighting on the principle factor; this process esti-
mates how different modalities will co-vary (approximately) with 
each other. For this example, with only six modalities to choose 
from, we opted for a simple experiment space with modalities 
given an integer between 1–6, based on the output of the factor 
analysis and the optimisation algorithm output integers. For more 
realistic situations with more complicated spaces (e.g., with many 
modalities organised along multiple dimensions and with more 
continuous modalities) one could use alternative (e.g., ratio) 
scales.
Subsequently, we performed Bayesian optimisation using the 
remaining 20% of participants, allowing the algorithm to pick 
the modality for a given individual, with the target objective of 
finding the minimum z-score. Given the relatively small number 
of available modalities, we allowed the algorithm to randomly 
choose three modalities (the burn-in phase) to sample first, to 
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fit a Gaussian process regression and then to use the expected- 
improvement acquisition function to choose the next point to 
sample. The expectation was that after some initial random 
exploration, the model should be able to take advantage of the 
covariance across individuals to estimate the modality with the 
minimum z-score more frequently than expected by chance.
To assess whether this optimisation approach was performing 
above chance levels, we compared results for each individual 
with the correct factor ordering of modality (based on the 
covariance structure across individuals) with a random order-
ing of modalities. For each individual the order of the modalities 
was randomised (i.e., the ordering of the modalities was no longer 
based on prior information about how individuals co-vary across 
modalities). For both random and true covariance models, we 
calculated the proportion of participants where the optimisation 
algorithm correctly found the minimum z-score modality. 
This assessment process was repeated 100 times with different 
random seeds, allowing different burn-in sampling trajectories for 
each individual for each iteration.
Data acquisition
In Scenario 1, data were acquired from 13 participants: seven 
healthy controls with no history of neurological problems 
(average age= 56, range = 46 to 67, female=4); and, six patients 
with chronic left-hemisphere middle-cerebral artery focal strokes 
(average age= 60, range = 47 to 78, female=2, average lesion 
volume= 10.6 cm3). For each participant, three T1-weighted 
scans were acquired at different voxel resolutions: 1mm3, 
2mm3, 4mm3. As with other data presented here, the patient and 
control data were not collected in real-time, but is intended to 
illustrate the general utility of the approach. In this example, 
we use seven healthy controls as a “normative” sample; this is, 
obviously, far too small for actual practical uses, but was limited 
by the data set available (multiple resolutions per individual) but 
does illustrate the potential of the approach if scaled-up.
For Scenarios 2 and 3, multimodal MRI data from 611 people 
(age range from 18–88, 312, female) were taken from the 
Cam-CAN dataset. This data consisted of T1-weighted, 
T2-weighted, diffusion-weighted MRI, three functional scans 
(resting-state fMRI, movie-watching fMRI and a blocked 
sensorimotor task-based fMRI). Imaging acquisition has been 
presented in detail elsewhere (Shafto et al., 2014).
Implementation
All analyses were performed with Matlab Version 2017b. Given 
the relatively low computational requirements of the analyses 
reported here, there are no additional minimum system 
requirements over and above those required to run this version of 
Matlab. Matlab code and associated data is available at Github 
(Leech & Cole, 2018).
Operation
Image pre-processing
Scenario 1:
To explore the feasibility of processing brain images in near 
real-time and to make minimal assumptions about the location 
or nature of pathology when calculating outlier distance, we 
used very simple and rapid pre-processing. T1-weighted images 
were converted from DICOM to NifTI format before being 
linearly-registered into MNI152 1mm3 space using the very 
efficient registration tool NiftyReg Version 1.3.9 (Modat, 2012). 
The same process was performed for each of the three different 
image resolutions acquired.
Scenario 2 & 3:
T1-weighted MRI. All T1-weighted structural images from all 
three datasets were processed in the same way as follows. Grey 
matter (GM), white matter (WM) and cerebrospinal fluid (CSF) 
volumes were calculated using SPM12 ‘Segment’ (University 
College London, UK). Voxelwise assessment of changes to brain 
volume was calculated using the SPM symmetric diffeomorphic 
registration process (Ashburner, 2007) to a predefined template 
used in our previous studies (Cole et al., 2018).
For the Cam-CAN dataset, the other modalities were (briefly) 
processed as detailed below. These analyses are merely illustra-
tive of the type of data that could be extracted; they have been 
simplified from multivariate raw data for each individual into 
a single summary statistic, chosen for its simplicity rather than 
because it is optimal for measuring individual variability.
Diffusion-weighted MRI. White-matter microstructure was 
analysed under the diffusion tensor imaging (DTI) paradigm, 
using FSL Version 5.010 tract-based spatial statistics (Smith et al., 
2006) with DTI-TK (Zhang et al., 2007) software for affine then 
non-linear tensor-based image registration. Normalised tensor 
images were used to derive voxelwise measures of fractional 
anisotropy (FA) and mean diffusivity. Mean values across major 
WM fibre tracts, taken from the JHU-ICBM tract atlas, were 
calculated, resulting in an FA average value per individual.
T2-weighted MRI. The same diffeomorphic transformation that 
was calculated for the grey matter was applied to the T2-weighted 
scan data to warp each individual’s data into the same T1-weighted 
template space. Subsequently, the average T2-weighted intensity 
values from the normalised image was calculated.
Resting state functional connectivity. Measures of ‘within- 
network’ connectivity were calculated from resting-state fMRI 
data using FSL ‘Dual Regression’ (Filippini et al., 2009). Prior 
to the dual regression, the standard FSL ‘MELODIC’ analysis 
pipeline was applied (Smith et al., 2004): high-pass temporal 
filtering at 100s, spatial smoothing at 5mm FWHM, global 
intensity normalisation, motion-correction followed by realign-
ing the data into MNI152 space using linear registration before 
the data were resampled into 4x4x4mm voxel space. Then the 
data were cleaned by linearly regressing six motion parameters 
from each voxel’s time-course, before nuisance WM and CSF 
time-courses were linearly regressed from each voxel (using 
average CSF and WM masks from the segmentation). Subse-
quently, using canonical spatial maps of twenty networks (including 
both intrinsic connectivity networks and likely noise networks) 
(Smith et al., 2009), cleaned data underwent a multiple regression 
to derive voxelwise measures of connectivity for each network 
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for each individual. Finally, to keep this aspect of the approach 
as simple as possible, we averaged all voxels within the default 
mode network (DMN) mask; this process resulted in an indi-
vidualized ‘within-network’ connectivity measure for the DMN. 
Future work (with any fMRI data) could explore only using short 
segments of the functional time-series (rather than the whole 
scan), to allow for faster, repeated measurements.
Movie-watching functional connectivity. This was identical 
to the analysis of the resting state connectivity, calculating 
individualised within-DMN functional connectivity while 
watching the movie.
Task fMRI. The sensorimotor task data were analysed 
following a standard FSL pipeline: global intensity normalisa-
tion, high-pass temporal filtering at 100s, spatial smoothing at 
5mm FWHM, motion-correction, registration of the data into 
MNI152 space using linear registration. Subsequently, a gen-
eral linear model was applied voxelwise (using the standard 
FSL approach for dealing with the auto-correlation of residuals 
(Smith et al., 2004)), with separate explanatory variables model-
ling auditory and visual blocks convolved with a canonical hemo-
dynamic response function. Subsequently, a contrast of all task 
conditions versus the implicit baseline was calculated and a 
higher-level group mixed-effects model was used to calculate 
increased and decreased BOLD activity with task. This resulted 
in group task positive and task negative networks which were 
converted into binary mask defined by voxels that survived 
cluster correction for multiple comparisons. An individualised 
task fMRI measure was calculated by taking the average activity 
within the positive network mask and subtracting the average value 
from the negative network mask.
Results
Scenario 1: Changing structural scan resolution to detect 
stroke pathology
The simplest Active Acquisition model involves starting with 
a rapid, low resolution structural scan, analysing it and then 
deciding to whether to acquire further higher-resolution scan(s). 
Here, we collected lower-resolution (4mm3) structural scans 
from six patients with focal brain lesions and seven age-matched 
controls, followed by intermediate-resolution (2mm3) and 
higher-resolution (1mm3) scans. An illustrative patient at three 
resolutions is presented in Figure 1 (left). Even with the low-
est resolution scan, patients and control participants (Figure 1 
- right) show a large difference in terms of outlier distance. This 
example, in patients with large focal strokes, illustrates how 
data simple measures calculated in near real time, and then a 
decision made as to whether a slower, higher resolution scan 
is needed or not. As can be seen from the outlier measurements, 
only a subset of the control participants, close to the boundary 
with the patients would require slower, additional scans.
Figure 1. Left, a stroke patient with three different resolution T1-weigthed scans. Right, outlier distance from control participants, for each 
participant for the three different scans, and combining all three scans. For each scan, the scan is subdivided into three, and the maximum 
outlier distance (out of the three subdivisions assessed) from the control data is plotted. This shows a relatively clear difference in outlier 
distance between patients and controls. For most patients and controls (either far from 0 or close to 0 respectively), there is no need to collect 
additional higher resolution (slower) scans to differentiate the two groups.
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We also simulated optimising the scan field-of-view in near- 
real-time. In this case, at each resolution the brain is divided 
into thirds, and the negative outlier distance calculated for each 
third. The third that is most strongly classed as an outlier is then 
retained and subsequent, higher resolution scans, acquired just 
within that third. The process then repeats (Figure 2, top). This 
illustrates how a composite brain image can be built up out of 
increasing resolution scans. This could trade-off sensitivity for 
tissue contrast with increasing quantification of brain structure, 
while limiting scanning time.
Scenario 2: Active multimodal stratification of individual 
differences
When fitting the decision tree regression (Figure 3) to predict 
chronological age from neuroimaging data, the regression 
model contained multiple modalities (indicating its utility in a 
sequential acquisition and analysis procedure). It started with GM 
volume, consistent with previous data suggesting a strong rela-
tionship between GM and age (Good et al., 2001), with lower 
z-scores indicating older age. Subsequently, average WM FA 
was chosen, again with lower values relating to older age. Next, 
the model’s branches become very different, both in terms of 
modality chosen and number of scans required, depending on the 
route through the tree.
We observed that the mean absolute error (MAE) of age predic-
tion is 10.47 years and the median error 8 years. For compari-
son, the MAE calculated on the same data using a support vector 
regression approach with all of the data is very similar, was 
10.42 years, with a median error of 9.4 years. The predicted 
age performance is considerably worse than has been reported 
elsewhere for single modalities from the same dataset e.g., 
(Lancaster et al., 2018); this is to be expected given that, for illus-
trative simplicity, we have collapsed large, multivariable datasets 
into single summary statistics (i.e., a single value for grey matter 
probability per individualm etcetera). In practice, sequential 
decision methods incorporating multivariate datasets to utilise 
the full richness of the underlying data are needed to realise the 
potential of the approach.
Scenario 3: Active discovery of individual differences with 
multi-modal imaging
Here we simulated closed-loop Bayesian optimisation used to 
discover the modality for a given individual (from the holdout 
dataset) where the negative outlier distance is most (i.e., rela-
tive to normative data from the training dataset), shown in 
Figure 4. For the optimisation to work efficiently (i.e., faster 
than exhaustive search across modalities), it needs to take advan-
tage of covariance across modalities in individual differences. 
Figure 2. top, composite coronal slices (one for each of the six patients), built out of increasing resolution with different coverage 
T1-weigthed scans, restricting the scan volume to that quantified as most abnormal relative to the controls. This demonstrates that 
the very simple approach to subdividing the brain and quantifying outliers can be used to ‘zoom’ in on areas of pathology that are specific 
for individual patients.
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Figure 3. The decision tree regression model calculated on summary statistics for each of six modalities to predict individual age. At 
each node in the tree the z-scored data for a given individual are used to decide modality to use next or whether to stop at this point. This can 
happen in near-real time, with different individuals taking different routes through the tree, and with different numbers of scans. The estimated 
age is then approximated by the age at the leaf nodes.
Figure 4. Active discovery of individual differences across modalities, controlled by a closed-loop optimisation algorithm. Left, the 
trajectory of the algorithm as it traverses the modality space, estimating a model of which modalities a specific individual appears most 
abnormal in, without exhaustively sampling every point, before guessing which is the most abnormal. Right, proportion of participants in the 
holdout set where the optimisation algorithm correctly chose the modality most sensitive to abnormalities for both true and random modalities, 
and the decrease in estimated minimum z-statistic for true versus random organisation of modalities (repeated 100 times with different burn-in 
random initialisation of the models).
Page 8 of 19
Wellcome Open Research 2018, 3:145 Last updated: 15 MAY 2019
In Figure 4A, the order of modalities (Movie, Rest, Task, T2, 
FA, GM) reflects this covariance structure. This provides prior 
information that the optimisation algorithm can combine with 
some random initial samples (numbers 1–3 in Figure 4A, left) 
to build a Gaussian process regression model to predict the 
modality with minimum z-score (in this case number 4, T2).
By chance, the proportion of participants for whom the 
algorithm finds the modality with the minimum z-score is 
0.67 (given that it sampled four modalities in total). When the 
Bayesian optimisation algorithm utilises the estimated covari-
ance structure from the training dataset, the proportion increases 
to >0.72 on average (results in Figure 4B are presented from 
100 replications). We see that if the modality ordering is chosen 
randomly (rather than based on covariance across individuals 
from the training set) the average proportion of participants 
where the minimum modality is selected approximates that 
expected by chance (i.e., 0.67). We also see that this translates into 
an increase in the estimated minimum z-score found when using 
the optimisation algorithm compared to the random modality 
ordering. This difference between true and random ordering 
of modality search space is relatively modest (approximately 
5%). However, the dataset used in this example has very few 
modalities and thus a restricted search space and has a rela-
tively limited sample size. Also, we used somewhat coarse pre- 
processing and summary statistics. Applying this approach to 
on-going data collection in much larger projects or at clinical 
neuroimaging centres that scan large numbers of people, 
alongside the myriad of different MRI scan modalities available, 
means that this approach could be substantially improved and 
used much more powerfully for biomarker discovery.
Discussion
Here we outlined the Active Acquisition approach for optimis-
ing multimodal neuroimaging scan protocols. The examples are 
intended to illustrate the potential utility of Active Acquisition; 
by using this approach important decisions about the scan do 
not need to be in advance; how long to scan for, what modali-
ties to acquire, which regions of the brain to focus on. Rather, 
the precise nature of the scanning protocol is determined online, 
adapting to the individual in the scanner, optimising acquisi-
tion for a given set of circumstances. Our current goal has been 
to outline several broad scenarios that suggest how Active 
Acquisition could progress and its general potential, rather 
than provide evidence of a specific biomarker or indeed 
specific pipelines or analysis approaches. Here, we discuss 
future potential directions for Active Acquisition, in particu-
lar for diagnosis and stratification as well as for biomarker 
discovery. We envisage these two directions developing along 
independent but complementary lines. We also consider some 
practical issues that need to be overcome to take the approach 
forward and maximise its potential for clinical and scientific 
neuroimaging.
Clinical diagnosis
Perhaps the more obvious use case for Active Acquisition is 
in clinical diagnostics, and the stratification of individuals 
into subgroups. Incorporating Active Acquisition could lead 
to either shorter scanning sessions, or more accurate and more 
reliable data collection. Multiple imaging modalities are typi-
cally collected in a diagnostic clinical scanning session, many 
of which end up being unnecessary for accurate diagnosis. If 
the scanning session can be terminated early, when sufficient 
diagnostic certainty has been reached (as in Scenario 1), there 
would be a significant reduction in scanning time, reducing 
patient discomfort and scanning costs. Equally, by optimising 
the order of the scans (as in Scenario 2), tailored to the targeted 
disorder, this would potentially remove the need to collect all 
modalities, leading to the same benefits in terms of time, cost and 
patient comfort.
Alternatively, Active Acquisition could be used to produce 
more accurate diagnoses and to optimise certain modalities for 
clinical use that are currently not used in clinical settings. Active 
acquisition could make use of scanning time and resources 
more efficient; collecting repetitions of important scans (until a 
sufficient signal-to-noise ratio has been reached), or chang-
ing the scanning resolution or field-of-view to focus on potential 
abnormalities. This may be of particular use in relatively low 
signal-to-noise imaging modalities. For example, the pattern of 
brain damage presented Scenario 1 (focal ischaemic stroke) is 
evident even on very low resolution and low signal-to-noise 
structural scans; however, other neurological conditions may 
have far more subtle abnormalities and other modalities (e.g., 
arterial spin labelling, diffusion tensor imaging, resting state or 
task BOLD scans) have lower signal-to-noise, and may benefit 
from more spatially focused, repeated data acquisition.
A pertinent issue facing neuroimaging research in clinical 
samples is how to deal with heterogeneity within patient groups; 
particularly common in chronic neuropsychiatric diseases. The 
“average” best scanning protocol sequence may well not be 
optimal at identifying clinically relevant abnormalities in a 
specific individual. Potentially, different scans may be optimal for 
a given diagnosis in different individuals and at different points 
in the natural history of a disease. One major strength of active 
acquisition approaches is that they can more easily locate an 
individual patient’s “sweet-spot” from a large menu of possible 
scan types/parameters in a time-efficient manner, without having 
to exhaustively search through all possibilities.
Biomarker discovery
Finding biomarkers that sensitively detect individual variability 
linked to clinical and scientific questions is an important 
precursor to improving diagnosis and stratification. The appli-
cation of active acquisition illustrated in Scenario 3 presents 
a radically different way to achieve this: actively searching for 
modalities or scanning parameters give abnormal readouts for a 
single individual. This approach contrasts with the current 
typical approach to biomarker discovery which can be 
characterised as choosing a set of modalities prior to scanning 
that are thought  to be related to the clinical question, and then 
assessing them on a large group of patients and controls or 
subgroups of patients, to provide sufficient statistical power to 
detect average group differences. Active acquisition also has the 
benefit of attempting to focus on modalities only when they are 
likely to be abnormal for an individual relative to a normative 
dataset, which is potentially much more powerful than the 
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comparison of group averages, as well as leading intuitively to 
clinical applications of personalised medicine. Active acquisition 
also has the advantage of relying less on relatively arbitrary 
decisions that lead to a limited number of modalities being 
acquired, which means that the clinically-relevant sweet-spot for 
data acquisition is more likely to be found.
Active Acquisition could also avoid the potential problem of 
scanning protocols being determined based on biased or inaccu-
rate previous studies. Given the replication ‘crisis’ in biomedi-
cal research, such issues are becoming increasingly recognised 
as a serious problem in medical imaging. Active optimisation 
approaches (such as in Scenario 3) involve repeatedly cycling 
between prediction and hypothesis testing on out-of-sample 
data, and as such are less susceptible to data overfitting. Equally, 
active optimisation approaches like these also involve a form of 
implicit “pre-registration” (Lorenz et al., 2017). This makes it 
harder to engage in certain questionable research practices (e.g., 
p-hacking, post-hoc hypothesising (Poldrack et al., 2017)) that 
are currently thought to hamper the development of neuroimaging 
biomarkers.
One additional advantage of active optimisation is that it is able 
to estimate how an individual varies from normality across the 
whole of the search space, despite only sampling a subset of the 
modalities tested included in the space. While the gains observed 
were relatively minor in the current example, where only six 
modalities organised along one searchable dimension were 
considered, the potential benefit would grow as the space becomes 
larger and multidimensional. Using the optimisation algorithm to 
map out the entire possible space offers the potential for a very 
rich, but efficiently collected, description of how an individual 
differs from normality. The search space mapped out could 
involve observing multiple optima in a given individual and 
estimating modalities with higher and lower than typical 
signal. Subsequent offline higher-level modelling (e.g., cluster-
ing or other data reduction approaches) could then be applied 
across individuals to find frequent patterns of abnormality from 
across all modalities.
Need for different types of normative datasets
One major limiting step to the development of active acquisition is 
the need to have well-characterised variability across individuals 
in both healthy or ‘normal’ participants as well as  clinical 
samples and relevant subgroups. Achieving this will require 
developing large datasets from which to derive estimates of 
between-individual covariance.
Some simpler applications of Active Acquisition could be built 
with existing normative datasets. For example, when the prob-
lem involves deciding when to stop collecting more data because 
a sufficient signal-to-noise ratio has been reached, increasing 
confidence in the inferences made from these data. Other 
approaches could take advantages of new acquisition methods 
such as the very rapid multi-contrast images at the start of a scan 
(Skare et al., 2018) or synthetic imaging which are then used to 
decide whether to collect slower, higher resolution scans. To 
utilise these types of scans, existing datasets could be utilised to 
create sufficiently large normative models.
However, for other applications, such as when searching 
across modalities (Scenarios 2 and 3), the benefits of Active 
Acquisition may be most evident when the space of possible 
modalities/parameters to be considered is large but structured 
in some way. Indeed, while at present only a small number of 
imaging modalities are employed clinically, more modalities 
could be useful but only for stratifying specific subgroups. An 
accurate understanding of the covariance between modalities/ 
scan parameters relevant to the clinical or scientific question 
will be necessary for maximising the benefit from these 
approaches
In Scenario 3, where the optimisation algorithm maps out 
where an individual is maximally abnormal, understanding 
the covariance across imaging modalities in a healthy control 
group (possibly controlling for factors such as age) may suffice. 
Existing large-scale projects to produce large normative data-
bases have focused on small numbers of modalities collected in 
large numbers of people (e.g., UK Biobank (Sudlow et al., 2015), 
Human Connectome Project (Van Essen et al., 2013) and the 
Cam-CAN dataset presented here). One possible approach is 
to use meta-analyses of different imaging modalities to try to 
estimate covariance structure across modalities (capitalising 
on the fact that different large-scale projects have some shared 
modalities but also differ from each other). An even better 
approach would be to have large-scale data collection projects 
that explicitly seek to quantify covariance across many different 
imaging modalities/scan parameters. Ideally, this would involve 
many different representative individuals being scanned, but 
each with different subsets of modalities/scan parameters; 
subsequently, a large, comprehensive covariance matrix across 
individuals can be assembled out of the incomplete datasets 
from each individual. These normative datasets will allow active 
searching for how individual patients vary from normality 
across many modalities, useful for biomarker discovery, without 
requiring dedicated large multimodal datasets for each clini-
cal condition. Approaches such as Bayesian optimisation with 
Gaussian processes will allow us to start with relatively few 
assumptions (i.e., only approximate similarity across modalities 
near each other in the experimental search space which can be 
based on health control data); importantly, the approach should 
work for individuals even when there are areas of the experimental 
space that deviate from the normative data.
There are also likely to be some situations, however, where 
acquiring targeted multi-modal normative datasets for specific 
clinical conditions will also be important. For example, when 
performing diagnostics rather than discovery of biomarkers 
(more like in Scenario 2). In these situations, bespoke multi-
modal datasets may be necessary to arrive at a very specific 
quantification of the covariance between different modalities, 
in order to accurately guide the sequential decision making. In 
such situations, particularly, with rare disease groups, acquisition 
of such datasets would be far more challenging and may not be 
practical.
Methodological considerations
All methodological approaches come with costs and benefits; 
with Active Acquisition approaches one concern is that early 
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mismeasurement can lead to serious failures later on. For 
example, in Scenario 1, this could result in terminating scans 
prematurely without collecting sufficient data; or, e.g., in Sce-
nario 2, this could involve travelling down the wrong branch of the 
decision tree. In such situations, important information for 
diagnosis or biomarker discovery may not be collected. This 
cost of using active approaches will be most acute when the 
underlying covariation between scan modalities is well 
understood and the optimal scan type is known. In contrast, the 
way that we currently collect data in many exploratory studies 
(e.g., UK Biobank), it is likely that optimal scans for assess-
ing variability in an individual are being omitted. This reflects the 
classic exploration versus exploitation trade off well-known in 
computer science.
For the benefits of active exploration to be maximised, many 
choices have to be made regarding the acquisition function to 
guide exploration, how to decide when to stop searching, how to 
quantify abnormality or predict an individual’s classification. 
We have suggested several simple illustrative scenarios, but each 
comes with its own specific challenges and future directions. 
There is a long history of methodological developments for 
adaptive studies in clinical situations (Cornfield et al., 1969) 
(Hauskrecht & Fraser, 2000)(Alagoz et al., 2010). Future 
work is needed to incorporate some of the more sophisticated 
approaches developed in these other domains to neuroimag-
ing and ideally combine them multivariate classification and 
clustering approaches increasingly commonly used with MRI. 
In Scenarios 2 and 3, work is needed to understand what 
happens when there is not a single optimum modality to maxi-
mally quantify abnormality (Scenario 3) or multiple equally good 
paths through the decision tree (Scenario 2). Future work is also 
needed to evaluate how to robustly quantify the abnormality of 
an individual’s scan, considering the large number of voxels and 
possibly heterogeneous or diffuse pathologies. Equally, future 
work is needed to develop rapid and robust image pre- 
processing, so that it can occur in near real-time. Recent devel-
opments in deep learning offer promise, where for example 
a structural MR image can undergo an analogue of a complete 
pre-processing pipeline in a matter of seconds (Cole et al., 2017).
Finally, from an MR physics perspective, there are also a number 
of limitations and challenges. Actively altering the field-of-
view and resolution (as suggested in Scenario 1 where the scan 
zooms in on the site of injury) for 3D structural imaging may not 
have any benefits (in terms of time saved, increased resolution) 
given inherent trade-offs between tissue contrast, signal to noise 
and number of measurements acquired. However, a similar 
approach could be taken with other imaging modalities (e.g., 
arterial spin labelling, diffusion imaging) where increased signal 
to noise from restricting the number of slices or increasing the 
resolution may be beneficial. Equally, there may be differ-
ent sources of information that different resolutions and fields- 
of-view could acquire (e.g., rapidly assessing geometry at 
higher resolution and tissue contrasts at a lower resolution).
In summary, here we have presented Active Acquisition, a 
novel conceptual approach to how neuroimaging data could be 
collected. We have utilised advances in optimisation algorithms 
and harnessed large publicly-available neuroimaging databases 
to develop Active Acquisition. This approach embeds data 
analysis into the acquisition process, allowing information to be 
obtained and employed for making online decisions about the 
optimal scans or parameters for a given clinical or scientific goal. 
While Active Acquisition is still at the embryonic stage, our 
intention with this manuscript and the illustrative examples 
contained herein, is to provide the groundwork for future 
conceptual and experimental work aimed at optimising the 
acquisition of neuroimaging data for clinical and scientific 
purposes.
Software availability
Underlying code used to perform this method is available from 
GitHub: https://github.com/ActiveNeuroImaging/MultimodalAc-
tiveAcquisition.
Archived source code at time of publication: http://doi.org/ 
10.5281/zenodo.1478784 (Leech & Cole, 2018)
Licence: MIT
Data availability
The anonymised and pre-processed data used in all scenarios is 
available from the same Github repository as the code. The MRI 
data has been provided in an anonymised format and registered to 
an average template space.
Github: https://github.com/ActiveNeuroImaging/MultimodalAc-
tiveAcquisition 
Zenodo. Dataset 1: ActiveNeuroImaging/MultimodalActive 
Acquisition: v1.0 http://doi.org/10.5281/zenodo.1478784 
(Leech & Cole, 2018)
This dataset is available under a MIT license.
The original data used in Scenarios 2 and 3 was from the 
Cambridge Centre for Ageing and Neuroscience (CamCAN) project 
dataset: https://camcan-archive.mrc-cbu.cam.ac.uk/dataaccess/ 
Media
Video 1: General illustrative video of one active acquisition 
approach for structural neuroimaging. (If video fails to play, it is 
also available from the Github repository).
https://doi.org/10.6084/m9.figshare.7296920.v1 (Cole et al., 2018)
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This is a paper about a method called active acquisition. The authors propose a framework where
neuroimaging sequence selection is iteratively optimized while the patient is on the table using an active
learning approach. The method is currently a simulation. At this point the paper is an outline of a research
strategy not a presentation of a method that is actually working.
In practical terms, the speed of the computation will be critical. If the computation increases the time that
the patient spends in the scanner, this will result in resistance to using this approach.
My main concern is that the three scenarios are spread widely and mostly talk about the concept. In my
opinion the authors should limit themselves to one scenario and flesh it out with enough detail that the
work could be duplicated.
 
:Introduction
“Active learning also has another important feature; they involve a prediction and testing cycle..”
they or it?
“using information gained from previous scans actively seek out brain abnormalities or make
diagnostic predictions…” should read “to actively seek..”
:Methods
Scenario 1: detection of stroke pathology
Choice of parameters: 
How about a short summary of Dataset 1? The paper should be self-contained.
“At each iteration the scan…” which scan? Is it at full resolution or, as implied in the introduction, at
reduced resolution? How much reduction?
What is a normative sample and where is it coming from?
Outlier distance:
When you say median distance, what do you mean? Distance in voxels, signal intensities,
something else?
Scenario 2: choose a modality
Again, provide a short description of the data set, so the reader does not have to visit a different
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 Again, provide a short description of the data set, so the reader does not have to visit a different
webpage just to know what data you are using. Also, which modalities are you planning to use in
the simulation and why? I went to the Cam-CAN webpage and modalities include task based fMRI
and MEG. It is not clear to me how such acquisitions could be performed dynamically at need.
Scenario 3: discovery of individual differences.
“we attempt to actively learn which modality an individual is most likely to be an outlier in” - Please
reword.
The section data acquisition provides the details that would have been helpful to have when
reading the scenarios. There were no cross-references in the previous sections. The scenario
descriptions 2 and 3 do not mention that only a subset of the Cam-CAN data is being used.
:Results
Scenario 1: Figure 2 is not clear to me. What do you show when you mean composite?
Scenario 2:  It would be helpful to have two examples: a young and an old person and how their trajectory
in the regression is different.
Scenario 3: I do not understand what the results are. “Here we simulated closed-loop Bayesian
optimisation used to discover the modality for a given individual (from the holdout dataset) where the
negative outlier distance is most (i.e., relative to normative data from the training dataset), shown in Figure
4.”
:Discussion
The authors should begin the discussion of the results in the three scenarios and how they relate to
existing literature. Just stating that the current goal was to outline several broad scenarios before
going on to a broad discussion of what the simulated technique could be used for is not to my liking
and rather unconventional.
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Partly
Are sufficient details provided to allow replication of the method development and its use by
others?
Partly
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Partly
Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Medical image computing
I have read this submission. I believe that I have an appropriate level of expertise to state that I
do not consider it to be of an acceptable scientific standard, for reasons outlined above.
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 do not consider it to be of an acceptable scientific standard, for reasons outlined above.
 23 January 2019Reviewer Report
https://doi.org/10.21956/wellcomeopenres.16265.r34533
© 2019 Vidaurre D. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
 Diego Vidaurre
Department of Psychiatry, Oxford Centre for Human Brain Activity (OHBA), University of Oxford, Oxford,
UK
In this paper, Cole  . advocate for using adaptive decision procedures during the data acquisitionet al
stage such that data collection is optimised with regard to the question at hand.
I think this is conceptually a quite valuable contribution. Although the concepts are clear, my only 
negative comment is that it is sometimes slightly hard to follow in the details – although this does not get
in the middle of the general message too much.
For example: "To do this, we converted each modality to a z-score, then performed a factor analysis
(using Matlab) and calculated a single factor". One eventually gets an idea of what the authors mean, but
this could be expressed more clearly.
- What do they mean by convert each modality to a z-score, exactly? How do they do it? First I
understood that they normalised each voxel across subjects within each modality, but that's not what it's
meant.
- Perform factor analysis; is it done across subjects? i.e. the input factor is (no. subjects by modalities)?
To walk the reader through these details and being more explicit would make the reading  more
amenable.
Another example: why the objective in Scenario 3 is to find the minimum z-score? Could the authors
elaborate to make it more accessible?
Another slightly negative comment is that perhaps Example 1 is somewhat trivial. Isn't it standard practice
to do this? In any case, I guess it works to illustrate the point.
I particularly liked the Discussion, which I found informative and honest. I am a bit worried about the
normative data sets, given that differences in acquisition and preprocessing can make a huge difference
(for example, HCP and UKBiobank data are hardly comparable between them).
Relatedly, would it be possible to extend this paradigm of "choosing modality" to "tuning the
preprocessing pipeline"? Admittedly the acquisition is the most costly thing, but the same idea could
guide perhaps questions like whether to work in volumetric or surface space, which we know makes a big
difference in the HCP for example.
In this line, I was wondering whether having different versions of each modality (for example sensor and
source space in MEG) would enrich and improve the optimisation in the end? Intuitively I would think that
should be the case.
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 should be the case.
Minor:
"the objective underlying function is unknown and costly to evaluate: -> I would say that either it's
unknown or is costly. One can't evaluate (no matter at what cost) something that is unknown?
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Neuroscience, Machine Learning
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 21 January 2019Reviewer Report
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© 2019 Schnack H. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
   Hugo G Schnack
Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht
University, Utrecht, The Netherlands
This manuscript discusses the possible need to change the way neuroimaging is used for diagnostic
purposes. The authors argue that, currently, an (MRI) examination uses a fixed set of scan acquisitions (a
multimodal imaging protocol), i.e., the same protocol for every patient. This possibly means that either
some scans are acquired that are unnecessary for diagnosing this patient, and/or some other scans that
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 some scans are acquired that are unnecessary for diagnosing this patient, and/or some other scans that
are not part of the protocol should have provided better diagnostic information regarding this patient. The
authors suggest that changing to an adaptive way of acquiring neuroimaging data -which they call 'active
acquisition'- could address this issue of obtaining more efficiently better neuroimaging data, both for
clinical and scientific use.
Their method basically starts with acquiring some base scan, which is then analyzed. The information
obtained from this first scan is then used to decide what will be the next scan, and so on. The method thus
uses a decision tree to determine the multimodal acquisition set for each individual patient. Each patient's
acquisition set can thus differ both in length (number of scans) and in kind (modality, resolution, ...) from
other patients' sets.
The authors illustrate their ideas with three examples of possible implementations. The authors also state
that there are quite a number of (challenging) issues that need to be addressed before such an approach
could be of use. In the following I will discuss some of these points and raise some other issues that were
not addressed (enough) in the current manuscript.
Time
The factor time (or cost) is one of the main ingredients in the proposed method. Although the authors
state that faster processing tools need to be developed for their approach, the reader may at least expect
an educated estimate of the time that can be saved, by not acquiring unnecessary scans. This gain in
time is compensated by a loss of time due to image processing and analysis. Image reconstruction can
take quite some time, images probably have to be transferred to a dedicated computer system for further
processing, images need to be processed and analyzed and decisions need to be converted to setting up
the next acquisition. The current manuscript does not mention at all times, neither actual times for the
steps taken in their examples nor estimates for the steps not currently executed. This information,
together with estimates of savings due to new developments, should provide the reader a good
impression of whether or not the proposed approach is viable.
Economics
While time saving definitely benefits the patients, the effect on cost is less clear. If scanning takes less
time this might reduce the cost of scanning, but it is not clear how this is compensated by increased costs
for compute servers, data servers, network equipment and computer programmers on the one hand, and
the (for some scenarios) required building of normative databases on the other hand.
Also, although current examination protocols may (to some extent) lead to acquisition of scans that are
unnecessary for the diagnosis of this patient, these scans may later turn out to be useful, either for
additional diagnostic purposes, for contributing to (new) normative databases, or for scientific research. It
happens quite often that neuroimaging data acquired for some (scientific) purpose can be used to answer
new and different research questions. Being able to use these data lowers the cost involved in these new
studies. It would be worthwhile to have some discussion about this, including estimates regarding the
economical feasibility of the proposed method.
Validity
While walking along different investigation paths for different individual cases (scenario 1) clearly is a
sensible approach for making clinical diagnosis, for quantitative research this is different. Scenario 2 is
used to show how the proposed method can be used 'to quantify [an individual's] relationship to a
normative sample'. In this example, each patient' age is predicted based on 1 out of 6 different selections
of scans (Figure 3). It is unclear what the effect of individual-based feature selections is on the resulting
output (age, in this case). One may expect bias here and differences in accuracy and reliability, all
because of using scans that differ in number and/or modality. Apart from showing that the overall
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 because of using scans that differ in number and/or modality. Apart from showing that the overall
prediction accuracy is comparable to that of a state-of-the-art traditional modeling approach (as has been
done), the authors should provide a thorough analysis, comparing the different performance measures in
a detailed manner. More generally, the potential effects of the proposed method on the statistical validity
should be discussed.
Example scenarios - some specific comments:
Scenario 1.
This is a very straightforward example perfectly illustrating a potential application.
Some more information, however, may be expected regarding the following potential issues.
I can imagine that the process described here is already part of the current examination process, in
the sense that an MRI technician decides, after a first quick scan, how the acquire the next
(high-resolution) scan. How does the time-saving (if at all) relate to the potential loss in accuracy?
This scenario uses 'the highest outlier distance':
What if the lesion (or brain abnormality) is too small to have an effect that is statistically detectable?
What if the lesion lies half-way two thick slices from the first scan?
What if there are two (or more) lesions in different slices, or if there is longer lesions oriented
orthogonal to the slice orientation?
It is not clear what is depicted in Figure 1's right panel. Please clarify the caption.
Scenario 2.
This example is not very convincing, for two reasons:
1. The age estimation model is based on summary statistics rather than fully exploiting the richness of the
multimodal datasets.
2. The resulting age prediction is categorical, while a fully continuous prediction may be expected
(especially because of the first author's expertise in this field).
Scenarios 2 and 3. 
The authors, at the end, state that more advanced ways to incorporate the methods are needed. I
recommend that the authors carry out such an implementation themselves, for at least one of these
scenarios (preferably no. 2). Since, as the authors acknowledge, the advantages from the current
implementations are modest (scenario 3), such an implementation would be helpful to fully show the
advances of their proposed method.
All in all, the current manuscript reports about a very interesting approach to innovate the way
neuroimaging data are acquired. However, to convince the reader of the potential of this approach, more
supportive data and discussion is needed.
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
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 Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Partly
Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Neuroimaging, data analysis, machine learning
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
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